Stay updated on IL-15 Combo with Nivolumab & Ipilimumab in Refractory Cancers Clinical Trial

Sign up to get notified when there's something new on the IL-15 Combo with Nivolumab & Ipilimumab in Refractory Cancers Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the IL-15 Combo with Nivolumab & Ipilimumab in Refractory Cancers Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.0.2 (replacing v3.0.1), and the Back to Top element has been removed.
    Difference
    0.4%
    Check dated 2025-09-13T17:44:00.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. Additionally, a 'Back to Top' feature has been added for improved navigation.
    Difference
    0.4%
    Check dated 2025-09-06T15:26:51.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The web page has added a facility name and location details, while removing specific location terms and listed countries. These changes enhance the clarity of the page's content regarding the facility's geographical context.
    Difference
    100%
    Check dated 2025-08-30T12:13:11.000Z thumbnail image
  4. Check
    24 days ago
    No Change Detected
  5. Check
    31 days ago
    Change Detected
    Summary
    The web page has been updated from version v2.16.11 to v2.16.12.
    Difference
    0.3%
    Check dated 2025-08-16T04:49:17.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.10 to version 2.16.11.
    Difference
    0.3%
    Check dated 2025-08-09T00:06:28.000Z thumbnail image
  7. Check
    46 days ago
    Change Detected
    Summary
    The web page has undergone significant deletions of core content related to clinical trials, including details about study types, results, and various identifiers. Additionally, a new revision number has been added.
    Difference
    55%
    Check dated 2025-08-01T19:32:58.000Z thumbnail image

Stay in the know with updates to IL-15 Combo with Nivolumab & Ipilimumab in Refractory Cancers Clinical Trial

Enter your email address, and we'll notify you when there's something new on the IL-15 Combo with Nivolumab & Ipilimumab in Refractory Cancers Clinical Trial page.